Ensoma

About:

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

Website: https://ensoma.com

Twitter/X: EnsomaBio

Top Investors: Alexandria Venture Investments, F-Prime Capital, Cormorant Asset Management, Catalio Capital Management, Bill & Melinda Gates Foundation

Description:

Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.